Skip to Main Content

Clinical Studies and Protocols

Site Map Investigators Log-in
(JFR-0982) Inflammation in Hidradenitis Suppurativa

 Return to List of Clinical Studies
 Return to List of Protocols for Psoriasis and Skin Diseases
Assessment of Inflammatory Mediators in Hidradenitis Suppurativa

Principal Investigator:
John Frew MD


Contact Information:
Clinical Research Support Office
1230 York Ave
New York, NY 10065
Telephone: 1(800)782-2737
Enrollment Status:
Open to Enrollment

Brief Summary of Protocol:
Researchers at The Rockefeller University are seeking to understand how hidradenitis suppurativa develops in the body.

Detailed Description of Protocol:
The researchers at the Rockefeller University Hospital are performing research on a disease called Hidradenitis Suppurativa (HS). HS is a chronic disease of the skin causing swelling, redness, pain, oozing, wounds and deep cysts under the skin. These changes normally occur in the armpits, groin and under the breasts, however they can occur anywhere. Some people find this disease runs in families also.
Researchers are doing this research to understand how certain chemicals and proteins which normally work to help protect us against infections (called cytokines) in the body (in the skin, blood and discharge from the wound) interact to cause HS, and if different people have different types of chemicals (cytokines) that cause their HS. Certain treatments currently used for HS block these chemicals (cytokines) and by understanding which ones are the most important in the development of HS, we may be able to identify new ways to effectively treat the disease.
We also know that certain conditions that people have (such as obesity and diabetes) and things that they do (such as smoking) can change the chemicals (cytokines) in their body. Therefore, we are collecting information about your other medical conditions and habits to see if these affect the level of chemicals (cytokines) in your body.

What specifically makes a person eligible for the study?
You may be eligible to enter this study:

- At least 13 years of age
- Have been diagnosed with hidradenitis suppurativa


At least 13 years old

Children permitted to participate:

Potential Benefits.....

Compensation is provided.